Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome - A prospective study in 342 patients

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome - A prospective study in 342 patients
复制标题

DOI:
10.1097/00005792-199601000-00003
复制
发表时间:
1996-01-01
期刊:
影响因子:
1.6
通讯作者:
Casassus, P
Casassus, P
中科院分区:
医学4区
文献类型:
--
作者:
Guillevin, L;Lhote, F;Casassus, P

文献摘要

被引文献

相似文献

来自内科(LC、FL、MG、P. Cohen、BJ、OL、P. Casassus)、阿维森医院、巴黎北部大学、博比尼和流行病学和统计系(NT、P. Casassus)、法国维勒瑞夫 INSERM Unité 21。这项工作基于前瞻性试验,并得到了国家健康与医学研究机构 (INSERM)、法国国家保险局 (CNAMTS) 和死灵研究协会 (ARAN) 的资助。研究是在法国国家医学协会 (SNFMI) 和结节性多动脉炎合作研究小组的帮助下进行的,该小组由以下主要研究人员和机构组成:M. Alcalay、O. Pourrat(普瓦捷); P. Amarenco、B. Amor、O. Blétry、A. Bussel、J. Cabane、B. Christoforov、J. Debray、F. Delrieu、J. Fermanian、P. Godeau、G. Huchon、JM Idatte、JC Imbert、J. Ph. Jaïs、MF Kahn、D. Laplane、C. Laroche、J. Lecoz、Lê THD、A. Marsac、R. Marteau、D. Molle、P. Pasquier、B. Pépin、JC Piette、A. Schannen、D. Sereni、B. Wechsler、JM Ziza(巴黎); G. Andreu、D. Daupleix、P. Dreyfus、L. Guillevin、JN Hugues、A. Léon、J. Sebaoun [已故]、(博比尼); KS Ang,JM Simon,(圣布里厄); Arlet, J. Pourrat 博士(图卢兹); P. Babinet(圣但尼); J. Baillet、JP Ducroix、A. Fournier、R. Makdassi、S. Smail(亚眠); G. Baralis(阿尔勒); J. Barrier、T. Ponge(南特); JM Beaufils(马耶讷); M. Bentata-Pessayre(圣日耳曼); E. Bercoff、O. Deshayes、B. Desrumeaux、B. Pinel,(鲁昂); JF Besancenot、JM Chalopin、Y. Tanter,(第戎); M. Bourel、Ph. Brissaud、S. Gié、P. Grosbois,(雷恩); J. Brun、B. Hurault De Ligny(卡昂);卡桑博士(维希); JP Cassuto、P. Dujardin、JG Fuzibet、JF Quaranta,(尼斯); F. Cordier(拉瓦尔); F.库仑,J.马勒库尔,(德勒); JF Delfraissy(克拉马尔); R. Desproges-Gotteron、F. Liozon、R. Treves、E. Vidal,(利摩日); G. Dorsit(穆兰); P. Dournovo(欧博讷); Y.埃查德(蒙费梅伊); E. Eliazewicz、B. Roualdes、JC Roujeau、A. Schaeffer、A. Sobel、M. Vantderstigel(克雷泰伊); A. Faradji、R. Himler,(斯特拉斯堡); A.弗朗哥(格勒诺布尔); C. Guillemot,M. Huart(拉罗什苏尔-永); G.贾宁(梅肯); V.Jeantils(邦迪); J. Jouquan、Y. Pennec(布雷斯特); P. Lebon(勒芒)、V. Lemaitre(瓦朗谢讷); A. 莱昂纳德(埃尔伯夫); H. Mallet(托农莱班); JC Marche(克莱蒙费朗); M. Mougeot-Martin、G. Pagniez (Creil); G.奥斯特曼(兰斯); J. Pasquier、C. Trépo、D. Vital-Durand(里昂); AM Piette(叙雷讷); F.罗西(旺多姆); H. Rousset(圣艾蒂安); M.鲁埃尔(桑利斯); L. Sary(沙特尔); B. De Toffol(图尔); P. Veyssier(贡比涅); B. 你(南希)。请求重印的地址:Dr. Loïc Guillevin, Department of Internal Medicine, Hôpital Avicenne, Université Paris-Nord, 125 Route de Stalingrad, 93000 Bobigny, France。 17 大脑受累是中小动脉全动脉炎的结果。这组血管炎并不均质,包括典型的结节性多动脉炎 (PAN),其特点是中等大小的动脉受累,有时血管造影显示微动脉瘤;显微镜下多血管炎,影响小动脉,有时导致快速进展的肾小球肾炎和肺泡出血(33); Churg-Strauss 综合征 (CSS),其特征为哮喘、嗜酸性粒细胞增多以及中小血管受累,伴或不伴肉芽肿 (7)。这些系统性血管炎部分表现为常见的临床和生物学症状 (22),其临床结果反映了一些需要识别的临床表现,因为应选择治疗方法……
From the Department of Internal Medicine (LC, FL, MG, P. Cohen, BJ, OL, P. Casassus), Hôpital Avicenne, Université Paris-Nord, Bobigny and the Department of Epidemiology and Statistics (NT, P. Casassus), INSERM Unité 21, Villejuif, France. This work was based on prospective trials supported by grants from the Institut National pour la Santé et la Recherche Médicale (INSERM), the Caisse Nationale d'Assurance-Maladie des Travailleurs Salariés (CNAMTS), and the Association pour la Recherche sur les Angéites Nécrosantes (ARAN). Research was carried out with the help of the Société Nationale Française de Médecine Interne (SNFMI) and the Cooperative Study Group for Polyarteritis Nodosa, which is composed of the following principal investigators and institutions: M. Alcalay, O. Pourrat (Poitiers); P. Amarenco, B. Amor, O. Blétry, A. Bussel, J. Cabane, B. Christoforov, J. Debray, F. Delrieu, J. Fermanian, P. Godeau, G. Huchon, JM Idatte, JC Imbert, J. Ph. Jaïs, MF Kahn, D. Laplane, C. Laroche, J. Lecoz, Lê THD, A. Marsac, R. Marteau, D. Molle, P. Pasquier, B. Pépin, JC Piette, A. Schannen, D. Sereni, B. Wechsler, JM Ziza (Paris); G. Andreu, D. Daupleix, P. Dreyfus, L. Guillevin, JN Hugues, A. Léon, J. Sebaoun [deceased],(Bobigny); KS Ang, JM Simon,(St-Brieuc); Ph. Arlet, J. Pourrat,(Toulouse); P. Babinet (St-Denis); J. Baillet, JP Ducroix, A. Fournier, R. Makdassi, S. Smail,(Amiens); G. Baralis (Arles); J. Barrier, T. Ponge (Nantes); JM Beaufils (Mayenne); M. Bentata-Pessayre (St-Germain); E. Bercoff, O. Deshayes, B. Desrumeaux, B. Pinel,(Rouen); JF Besancenot, JM Chalopin, Y. Tanter,(Dijon); M. Bourel, Ph. Brissaud, S. Gié, P. Grosbois,(Rennes); J. Brun, B. Hurault De Ligny (Caen); Ph. Cassan (Vichy); JP Cassuto, P. Dujardin, JG Fuzibet, JF Quaranta,(Nice); F. Cordier (Laval); F. Coulomb, J. Mallecourt,(Dreux); JF Delfraissy (Clamart); R. Desproges-Gotteron, F. Liozon, R. Treves, E. Vidal,(Limoges); G. Dorsit (Moulins); P. Dournovo (Eaubonne); Y. Echard (Montfermeil); E. Eliazewicz, B. Roualdes, JC Roujeau, A. Schaeffer, A. Sobel, M. Vantderstigel (Créteil); A. Faradji, R. Himler,(Strasbourg); A. Franco (Grenoble); C. Guillemot, M. Huart (La Rochesur-Yon); G. Janin (Macon); V. Jeantils (Bondy); J. Jouquan, Y. Pennec (Brest); P. Lebon (Le Mans), V. Lemaitre (Valenciennes); A. Léonard (Elbeuf); H. Mallet (Thonon-les-Bains); JC Marche (Clermont-Ferrand); M. Mougeot-Martin, G. Pagniez (Creil); G. Osterman (Reims); J. Pasquier, C. Trépo, D. Vital-Durand (Lyon); AM Piette (Suresnes); F. Rossi (Vendôme); H. Rousset (St-Étienne); M. Ruel (Senlis); L. Sary (Chartres); B. De Toffol (Tours); P. Veyssier (Compiègne); B. You (Nancy). Address reprint requests to: Dr. Loïc Guillevin, Department of Internal Medicine, Hôpital Avicenne, Université Paris-Nord, 125 route de Stalingrad, 93000 Bobigny, France. 17 ceral involvement that are the consequence of panarteritis of small-and medium-sized arteries. This group of vasculitides is not homogeneous and comprises classic polyarteritis nodosa (PAN), char-acterized by medium-sized artery involvement and sometimes microaneurysms on angiography; micro-scopic polyangiitis, which affects small-sized arteries and is sometimes responsible for rapidly progres-sive glomerulonephritis and alveolar hemorrhage (33); and Churg-Strauss syndrome (CSS), which is characterized by asthma, hypereosinophilia, and involvement of medium-and small-sized vessels with or without granuloma (7). These systemic vasculitides present in part with common clinical and biologic symptoms (22), and their clinical outcomes reflect some clinical manifes-tations that need to be identified, because the treat-ment should be chosen …